Nature's Sunshine (NASDAQ:NATR) Beats Q4 Sales Targets
Wellness products company Nature’s Sunshine (NASDAQ:NATR) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 8.5% year on year to $118.2 million. The company expects the full year’s revenue to be around $457.5 million, close to analysts’ estimates. Its non-GAAP loss of $0 per share was significantly below analysts’ consensus estimates.